Other versions:

(Verbatim name)

ID

(Catalog Number)

ORG

DES

Invalid DOI was provided, please try again

XML
PDF
 
 
Bluesky
Twitter
Facebook
Telegram
Mendeley
Reddit
Notify a colleague
  • ContentsContents
  • Article InfoArticle Info
  • CiteCite
  • MetricsMetrics
  • CommentComment
  • RelatedRelated
  • FigsFigs
  • TabsTabs
  • RefsRefs
  • CitedCited
  • Article title
  • Abstract
  • Keywords
  • Introduction
  • Aim
  • Materials and methods
  • Results and discussion
    • Financial accessibility of medicinal products under AM
    • COVID-19 medicines under AM
    • Orphan medicines under AM
    • Medicinal products under AM added to the EMA list in 2023
    • Does the status of AM lead to an increase in ADRs reporting?
  • Conclusion
  • Author contributions
  • Conflict of interest
  • Acknowledgements
  • References
  • Supplementary Table
Subscribe to email alerts for current Article's categories
Powered by